On April 6, 2026, the tender offer for our common shares conducted by Takara Holdings Inc., our controlling shareholder (parent company), was successfully completed. Subsequently, at the Extraordinary General Meeting of Shareholders held on May 20, 2026, a share consolidation and partial amendments to the Articles of Incorporation were approved. As a result, the Company’s shares were delisted as of June 12, 2026.
Furthermore, it is expected that cash consideration for fractional shares resulting from the share consolidation will be distributed to shareholders around mid-September 2026.
|
Related IR News |
|
|
Notice Regarding Cancellation of Treasury Stock (April 27, 2026) |
|
|
Contact Information |
For inquiries regarding our shares prior to the delisting, please contact the securities firm with which you had transactions.
For inquiries regarding the tender offer and share consolidation, please contact:
Takara Bio Inc.
Public & Investor Relations Department
TEL: +81-77-565-6970
Email: (Inquiry Form) |
